DPYSL4

Chr 10

dihydropyrimidinase like 4

Also known as: CRMP3, DRP-4, ULIP4

The protein is necessary for signaling by class 3 semaphorins and subsequent cytoskeleton remodeling, playing a role in axon guidance, neuronal growth cone collapse and cell migration. Mutations in DPYSL4 cause autosomal recessive developmental and epileptic encephalopathy with microcephaly, presenting in infancy with seizures, severe developmental delay, and progressive microcephaly. The gene shows moderate constraint against loss-of-function variants, and the condition primarily affects the central nervous system with early onset neurological manifestations.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
0
P/LP submissions
P/LP missense
0.89
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryDPYSL4
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.89LOEUF
pLI 0.000
Z-score 2.02
OE 0.59 (0.410.89)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.15Z-score
OE missense 0.84 (0.770.92)
330 obs / 394.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.59 (0.410.89)
00.351.4
Missense OE0.84 (0.770.92)
00.61.4
Synonymous OE1.07
01.21.6
LoF obs/exp: 17 / 28.7Missense obs/exp: 330 / 394.0Syn Z: -0.71
DN
0.7131th %ile
GOF
0.6834th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DPYSL4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC